<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25003792</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-3397</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>7</Issue><PubDate><Year>2014</Year><Month>Jul</Month><Day>07</Day></PubDate></JournalIssue><Title>Marine drugs</Title><ISOAbbreviation>Mar Drugs</ISOAbbreviation></Journal><ArticleTitle>Deferoxamine compensates for decreases in B cell counts and reduces mortality in enterovirus 71-infected mice.</ArticleTitle><Pagination><StartPage>4086</StartPage><EndPage>4095</EndPage><MedlinePgn>4086-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/md12074086</ELocationID><Abstract><AbstractText>Enterovirus 71 is one of the major causative agents of hand, foot and mouth disease in children under six years of age. No vaccine or antiviral therapy is currently available. In this work, we found that the number of B cells was reduced in enterovirus 71-infected mice. Deferoxamine, a marine microbial natural product, compensated for the decreased levels of B cells caused by enterovirus 71 infection. The neutralizing antibody titer was also improved after deferoxamine treatment. Furthermore, deferoxamine relieved symptoms and reduced mortality and muscle damage caused by enterovirus 71 infection. This work suggested that deferoxamine has the potential for further development as a B cell-immunomodulator against enterovirus 71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yajun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, CAMS &amp; Comparative Medicine Centre, Peking Union Medical College, Beijing 100021, China. yangyajun484@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, CAMS &amp; Comparative Medicine Centre, Peking Union Medical College, Beijing 100021, China. alanyingtao519@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiu</LastName><ForeName>Jinghui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, CAMS &amp; Comparative Medicine Centre, Peking Union Medical College, Beijing 100021, China. xiujinghui1984@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, CAMS &amp; Comparative Medicine Centre, Peking Union Medical College, Beijing 100021, China. bailin49@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Feifei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, CAMS &amp; Comparative Medicine Centre, Peking Union Medical College, Beijing 100021, China. guanff@cnilas.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, CAMS &amp; Comparative Medicine Centre, Peking Union Medical College, Beijing 100021, China. zhangl@cnilas.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jiangning</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, CAMS &amp; Comparative Medicine Centre, Peking Union Medical College, Beijing 100021, China. liujn@cnilas.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lianfeng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, CAMS &amp; Comparative Medicine Centre, Peking Union Medical College, Beijing 100021, China. zhanglf@cnilas.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Mar Drugs</MedlineTA><NlmUniqueID>101213729</NlmUniqueID><ISSNLinking>1660-3397</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>J06Y7MXW4D</RegistryNumber><NameOfSubstance UI="D003676">Deferoxamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003676" MajorTopicYN="N">Deferoxamine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25003792</ArticleId><ArticleId IdType="pmc">PMC4113816</ArticleId><ArticleId IdType="doi">10.3390/md12074086</ArticleId><ArticleId IdType="pii">md12074086</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu K.X., Ng M.M., Chu J.J. Developments towards antiviral therapies against enterovirus 71. Drug Discov. Today. 2010;15:1041&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108380</ArticleId><ArticleId IdType="pubmed">20974282</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.W., Leu Y.L., Horng J.T. Daphne Genkwa sieb. et Zucc. Water-soluble extracts act on enterovirus 71 by inhibiting viral entry. Viruses. 2012;4:539&#x2013;556. doi: 10.3390/v4040539.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v4040539</ArticleId><ArticleId IdType="pmc">PMC3347322</ArticleId><ArticleId IdType="pubmed">22590685</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Zhang T., Du J., Cui S., Yang F., Jin Q. Anti-enterovirus 71 effects of chrysin and its phosphate ester. PLoS One. 2014;9:e89668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943725</ArticleId><ArticleId IdType="pubmed">24598537</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Zhang T., Hu Y., Wang X., Du J., Li Y., Sun S., Sun X., Li Z., Jin Q. Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009. Virol. J. 2011;8:508. doi: 10.1186/1743-422X-8-508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-508</ArticleId><ArticleId IdType="pmc">PMC3227625</ArticleId><ArticleId IdType="pubmed">22054534</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.J., Lai C.C., Lai C.H., Sue S.C., Lin C.W., Hung C.H., Lin T.H., Hsu W.Y., Huang S.M., Hung Y.L., et al. Inhibition of enterovirus 71 infections and viral IRES activity by Fructus gardeniae and geniposide. Eur. J. Med. Chem. 2013;62:206&#x2013;213. doi: 10.1016/j.ejmech.2012.12.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2012.12.038</ArticleId><ArticleId IdType="pubmed">23353754</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.C., Kao C.M., Ling P., Su I.J., Chang T.M., Chen S.H. CD4 T-cell-independent antibody response reduces enterovirus 71 lethality in mice by decreasing tissue viral loads. Clin. Dev. Immunol. 2012;2012 doi: 10.1155/2012/580696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/580696</ArticleId><ArticleId IdType="pmc">PMC3486008</ArticleId><ArticleId IdType="pubmed">23133489</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.W., Chang K.C., Kao C.M., Chang S.P., Tung Y.Y., Chen S.H. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J. Virol. 2009;83:6477&#x2013;6483. doi: 10.1128/JVI.00434-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00434-09</ArticleId><ArticleId IdType="pmc">PMC2698549</ArticleId><ArticleId IdType="pubmed">19386699</ArticleId></ArticleIdList></Reference><Reference><Citation>Abzug M.J., Keyserling H.L., Lee M.L., Levin M.J., Rotbart H.A. Neonatal enterovirus infection: Virology, serology, and effects of intravenous immune globulin. Clin. Infect. Dis. 1995;20:1201&#x2013;1206. doi: 10.1093/clinids/20.5.1201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/20.5.1201</ArticleId><ArticleId IdType="pubmed">7620000</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao R.Y., Dong D.Y., Liu R.J., Han J.F., Wang G.C., Zhao H., Li X.F., Deng Y.Q., Zhu S.Y., Wang X.Y., et al. Human IgG subclasses against enterovirus Type 71: Neutralization versus antibody dependent enhancement of infection. PLoS One. 2013;8:e64024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3659118</ArticleId><ArticleId IdType="pubmed">23700449</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Z.Q., Wang J.F., Hao Y.Y., Wang Y. Recent advances in the discovery and development of marine microbial natural products. Mar. Drugs. 2013;11:700&#x2013;717. doi: 10.3390/md11030700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md11030700</ArticleId><ArticleId IdType="pmc">PMC3705366</ArticleId><ArticleId IdType="pubmed">23528949</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer D. Iron chelation as therapy for HIV and Mycobacterium tuberculosis co-infection under conditions of iron overload. Curr. Pharm. Des. 2006;12:1943&#x2013;1947. doi: 10.2174/138161206777442164.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161206777442164</ArticleId><ArticleId IdType="pubmed">16787239</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A., Meyer D. Desferrioxamine as immunomodulatory agent during microorganism infection. Curr. Pharm. Des. 2009;15:1261&#x2013;1268. doi: 10.2174/138161209787846801.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161209787846801</ArticleId><ArticleId IdType="pubmed">19355965</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.J., Zhang L.F., Fan X.X., Qin C., Liu J.N. Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo. Bioorg. Med. Chem. Lett. 2012;22:2209&#x2013;2211. doi: 10.1016/j.bmcl.2012.01.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2012.01.102</ArticleId><ArticleId IdType="pubmed">22342145</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.J., Xiu J.H., Zhang X., Zhang L., Yan K., Qin C., Liu J.N. Antiviral effect of matrine against human enterovirus 71. Molecules. 2012;17:10370&#x2013;10376. doi: 10.3390/molecules170910370.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules170910370</ArticleId><ArticleId IdType="pmc">PMC6268984</ArticleId><ArticleId IdType="pubmed">22932217</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.N., Wang W., Duo J.Y., Hao Y., Ma C.M., Li W.B., Lin S.Z., Gao X.Z., Liu X.L., Xu Y.F., et al. Combined peptides of human enterovirus 71 protect against virus infection in mice. Vaccine. 2010;8:7444&#x2013;7451.</Citation><ArticleIdList><ArticleId IdType="pubmed">20831911</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y.J., Xiu J.H., Liu J.N., Zhang L., Li X.Y., Xu Y.F., Qin C., Zhang L.F. Chebulagic Acid, a Hydrolyzable Tannin, Exhibited Antiviral Activity in Vitro and in Vivo against Human Enterovirus 71. Int. J. Mol. Sci. 2013;14:9618&#x2013;9627. doi: 10.3390/ijms14059618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms14059618</ArticleId><ArticleId IdType="pmc">PMC3676802</ArticleId><ArticleId IdType="pubmed">23644889</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>